- Home
- TAYD vs SGMO Comparison
TAYD vs SGMO Comparison
Compare TAYD & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAYD
- SGMO
- Stock Information
- Founded
- TAYD 1955
- SGMO 1995
- Country
- TAYD United States
- SGMO United States
- Employees
- TAYD N/A
- SGMO N/A
- Industry
- TAYD Industrial Machinery/Components
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TAYD Industrials
- SGMO Health Care
- Exchange
- TAYD Nasdaq
- SGMO Nasdaq
- Market Cap
- TAYD 150.7M
- SGMO 180.5M
- IPO Year
- TAYD N/A
- SGMO 2000
- Fundamental
- Price
- TAYD $42.99
- SGMO $2.82
- Analyst Decision
- TAYD
- SGMO Buy
- Analyst Count
- TAYD 0
- SGMO 3
- Target Price
- TAYD N/A
- SGMO $7.00
- AVG Volume (30 Days)
- TAYD 18.3K
- SGMO 5.8M
- Earning Date
- TAYD 01-08-2025
- SGMO 11-12-2024
- Dividend Yield
- TAYD N/A
- SGMO N/A
- EPS Growth
- TAYD 44.55
- SGMO N/A
- EPS
- TAYD 2.90
- SGMO N/A
- Revenue
- TAYD $46,277,035.00
- SGMO $52,291,000.00
- Revenue This Year
- TAYD N/A
- SGMO N/A
- Revenue Next Year
- TAYD N/A
- SGMO $11.46
- P/E Ratio
- TAYD $15.04
- SGMO N/A
- Revenue Growth
- TAYD 12.78
- SGMO N/A
- 52 Week Low
- TAYD $21.99
- SGMO $0.30
- 52 Week High
- TAYD $64.50
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- TAYD 40.94
- SGMO 70.33
- Support Level
- TAYD $44.52
- SGMO $1.80
- Resistance Level
- TAYD $46.51
- SGMO $2.08
- Average True Range (ATR)
- TAYD 2.24
- SGMO 0.25
- MACD
- TAYD -0.26
- SGMO 0.04
- Stochastic Oscillator
- TAYD 7.45
- SGMO 98.08
About TAYD Taylor Devices Inc.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.